Patients who have been treated for some lymphomas can develop robust antibody responses to COVID-19 vaccination – at least once their treatment is completed, say UK researchers. But others may never achieve a vaccine response however long ago their treatment ended. In an interim analysis of the UK PROSECO study, data from 129 patients showed ...
Early data unpicks COVID-19 vaccine effectiveness in lymphoma patients
By Emma Wilkinson
8 Jul 2021